Skip to main content
Clinical Trials/CTRI/2022/05/042804
CTRI/2022/05/042804
Recruiting
未知

A prospective interventional study to find the effectivity of Razumab by measuring macular edema pre and post intravitreal injection.

ESIC postgraduate institute of medical science and research0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: H00-H59- Diseases of the eye and adnexa
Sponsor
ESIC postgraduate institute of medical science and research
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
ESIC postgraduate institute of medical science and research

Eligibility Criteria

Inclusion Criteria

  • patients with diabetic macular edema or macular edema due to retinal vaso\-occlussive disease with central macular thickness of less or equal to 315 micron and visual acuity of less or equal to 0\.2 on LogMAR chart will be included in the study.

Exclusion Criteria

  • 1\. pre existing macular scar or dystrophy.
  • 2\.patients with active inflammatory and infectious diseases of the eye.
  • 3\. Patients already under treatment for macular edema in other hospital.
  • 4\.patients with history of recent ocular history or trauma.
  • 5\. patients with history of cerebrovascular or cardiovascular comorbidities.

Outcomes

Primary Outcomes

Not specified

Similar Trials